US pharma group to pay €90.5mn for 8% in deal that will boost joint Lyme disease programme
Pfizer buys stake in French vaccine maker Valneva
Related Posts
Sun Pharma Nears $12 Billion Acquisition of Organon: A New Frontier for Indian Pharma
TL;DR Mumbai-based Sun Pharmaceutical Industries Ltd. is finalizing a binding $12 billion offer for Organon & Co., marking the largest overseas acquisition in Indian pharma history. The deal is...
Merck’s $6.7 Billion Bid for Terns Pharma: A Strategic Play for Metabolic Leadership
TL;DR Merck & Co. has launched a $6.7 billion all-cash unsolicited offer for Terns Pharma, a biotech firm specializing in small-molecule drug candidates for metabolic disorders like NASH. The...
Alcon Abandons $430 Million Lensar Deal Citing Regulatory Drag; A Warning Shot for MedTech M&A
TL;DR Alcon terminated its agreement to acquire Lensar for up to $430 million on March 17, 2026, citing a protracted, year-long regulatory review by the Federal Trade Commission (FTC). The FTC...
Medtronic Locks in Full Neurovascular Workflow with $550M Scientia Vascular Acquisition
TL;DR Medtronic announced a definitive agreement on March 10, 2026, to acquire Scientia Vascular for approximately $550 million. The deal targets Scientia's advanced guidewires and catheters,...